Physician

Azhar Ali Malik, M.D.

According to 2025 Medicare claims, Azhar Malik, M.D. (NPI: 1366436875) practices nephrology in the Victoria, TX market, with the plurality of this provider's patient population coming from Victoria, TX. This provider's primary affiliated billing organization is VICTORIA KIDNEY & DIALYSIS ASSOCIATES (NPI: 1770545873; TIN: 760524482) and primary practice location at 77901-6060. Malik is affiliated with the CHSPSC ACO 6, LLC (ACO ID: A3712), The Rural Advantage LLC (ACO ID: A5257), Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), Main Street Rural Health Cottonwood ACO LLC (ACO ID: A5439), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Malik's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 764 traditional Medicare patients, billed 2,824 HCPCS/CPT codes, and received $298,771 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,290 prescription claims across 350 beneficiaries totaling $240,671 in drug costs, led by Jardiance (Empagliflozin). 2023 DME data shows 109 claims. Open Payments data shows 9 records totaling $185. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $475,118 to $298,771. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $788,518 to $240,671. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,207	5,155	$475,118
2016	1,293	5,436	$490,663
2017	1,298	5,530	$494,317
2018	1,294	5,623	$504,766
2019	1,293	5,599	$498,885
2020	1,127	4,870	$441,402
2021	1,050	4,423	$456,899
2022	879	3,866	$366,344
2023	780	3,296	$333,199
2024	764	2,824	$298,771

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	316	2,753	$788,518
2016	387	3,321	$1,006,394
2017	388	3,378	$825,207
2018	390	2,807	$459,134
2019	400	2,216	$292,397
2020	444	2,546	$262,353
2021	507	2,711	$259,849
2022	465	2,533	$250,218
2023	427	1,877	$250,394
2024	350	1,290	$240,671

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	167	$11,326
2016	29	341	$15,158
2017	47	353	$14,783
2018	26	202	$11,019
2019	73	309	$10,974
2020	77	529	$22,678
2021	66	445	$12,995
2022	N/R	252	$6,848
2023	N/R	109	$1,816
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	102	126	$133
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	95	101	$101
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	148	324	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	285	383	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	271	1,180	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	57	3,262	$62,937
Velphoro	Sucroferric Oxyhydroxide	14	409	$50,233
Sevelamer Carbonate	Sevelamer Carbonate	113	4,446	$38,393
Farxiga	Dapagliflozin Propanediol	40	2,144	$36,526
Eliquis	Apixaban	11	374	$7,488

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$185	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Azhar Ali Malik, M.D.?

Tedicare shows public-source Medicare data for Azhar Ali Malik, M.D. (NPI 1366436875), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Azhar Ali Malik, M.D. have ACO affiliation data?

Azhar Ali Malik, M.D. is shown with ACO affiliation data for CHSPSC ACO 6, LLC (MSSP, ACO ID A3712), The Rural Advantage LLC (MSSP, ACO ID A5257), Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), Main Street Rural Health Cottonwood ACO LLC (MSSP, ACO ID A5439), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Azhar Ali Malik, M.D.?

Azhar Ali Malik, M.D. is linked to VICTORIA KIDNEY & DIALYSIS ASSOCIATES (billing NPI 1770545873) in the available physician profile data.

Does Azhar Ali Malik, M.D. have Open Payments data?

Azhar Ali Malik, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.